| Name | Title | Contact Details |
|---|
Kolltan Pharmaceuticals is a private company founded in 2007 that is developing novel monoclonal antibody (mAb) drugs targeting receptor tyrosine kinases (RTKs). Kolltan's primary targets derive from seminal discoveries made in the laboratory of Dr. Joseph Schlessinger, Chairman of the Department of Pharmacology at the Yale School of Medicine, and in Kolltan’s laboratories. Dr. Schlessinger's laboratory has characterized a novel molecular mechanism underlying activation of RTKs providing, for the first time, a clear molecular explanation — at atomic resolution — for the oncogenic activity of mutations that have been identified in a variety of human cancers.
New England Institutional Review Board NEIRB is a Newton, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Sunquest Information Systems, Inc. provides healthcare information systems to large and mid-sized hospitals, clinics and other facilities, including integrated delivery networks comprised of multi-entity, multi-site healthcare organizations.
Central Massachusetts Independent Physician Association is a Worcester, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Health New England Inc is a Springfield, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.